AN2 Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Menlo Park, CA
SEC filing record 1 source field available
Fiscal year end
31 December
AN2 Therapeutics, Inc. has filed 381 SEC EDGAR filings since 24 Sep 2021

SEC filing history

Showing 226-250 of 381 matching filings.

Per page
25
Current page
10
4

FORM 4 SUBMISSION

Filing date
12 Jan 2024
Reporting date
10 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Jan 2024
Reporting date
09 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41331

144 filing

Filing date
10 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41331

144 filing

Filing date
10 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Jan 2024
Reporting date
02 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Jan 2024
Reporting date
02 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41331

144 filing

Filing date
02 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41331

144 filing

Filing date
02 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Nov 2023
Reporting date
14 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Nov 2023
Reporting date
14 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41331

144 filing

Filing date
14 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Oct 2023
Reporting date
29 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Oct 2023
Reporting date
29 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41331

144 filing

Filing date
02 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Sep 2023
Reporting date
27 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Sep 2023
Reporting date
27 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41331

144 filing

Filing date
29 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
15 Sep 2023
Reporting date
23 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
15 Sep 2023
Reporting date
23 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Sep 2023
Reporting date
23 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Sep 2023
Reporting date
23 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .